Durable complete response to PET ‐CT driven stereotactic radiation therapy plus pembrolizumab for pleomorphic Pancoast cancer: Case report and literature review

Key Clinical MessagePET-driven SBRT plus pembrolizumab as first-line therapy against pleomorphic Pancoast cancer appears beneficial, probably due to high equivalent doses of SBRT on photopenic necrotic core and synergic immune system stimulation of immunoradiotherapy.

Source: Clinical Case Reports - April 5, 2024 Category: General Medicine Authors: Alessandra Castelluccia, Angela Sardaro, Artor Niccoli  Asabella, Antonio Rosario Pisani, Dino Rubini, Maurizio Portaluri, Francesco Tramacere Tags: CASE REPORT Source Type: research